Pfizer reported lower 3rd quarter profits on Tuesday, October 27, as COVID-19 dented demand for some medicines from patients whose regular healthcare patterns were disrupted.
The company saw an 11% drop in its hospital business in emerging markets, primarily due to fewer elective surgeries in China and shorter in-patient hospital stays in the country.
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut: